Digestive Diseases
Wong CR, Flores YN, Avila A, Tieu L, Crespi CM, May FP, Bell DS, Glenn B, Bastani R. Improving the accuracy and precision of disease[...]
Vahedi F, Yalamanchi M, Issa D. Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration. Curr Opin Gastroenterol. 2025 Nov[...]
Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]
Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.
Kostiuk A, Jafari M, Wang C, Mayer E, Salamon N, Holly LT, Ellingson BM. Functional alterations across motor, visual, and attention cerebellar and cortical networks[...]
Yu KB, Son C, Özcan E, Chandra A, Paramo J, Varghese A, Roice A, Finnigan D, Chandra F, Novoselov A, Kazmi SA, Lum GR, Lopez-Romero[...]
Yang D, Robalino Gonzaga E, Hasan MK, Trindade AJ, Radlinski M, Burbridge RA, Mosko J, Taunk P, Jawaid S, Othman MO, Diehl DL, Khara HS,[...]
Vongsavath T, Tun KM, Mukhopadhyay D, Lo CH, Singh A, Amin R, Twohig P, Saab S, Manne V. Effect of Cystic Fibrosis Transmembrane Conductance Regulator[...]
Cumpian NA, Gutierrez JA, Wu W, Saab S. Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review. JAMA Intern Med. 2025 Sep 22.[...]
Frost S, Ambastha C, Patel D, Roney A, Greb A, Rangel-Garcia M, Sauk JS, Chang C, Park S, Parian A, Suchan A, Moughames E, Krishna[...]